Patents by Inventor Peter Ferdinand

Peter Ferdinand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7855191
    Abstract: Disclosed is an agent which has a destructive effect on malignant tumors and contains alpha-ketoglutaric acid, N-acetyl-seleno-L-methionine, N-acetyl-L-methionine, and a compound that is capable of forming azomethine and is selected among the group 5-hydroxymethylfurfural, dehydroascorbic acid, maltol, and vanillin as an active substance, 5-hydroxymethylfurfural being preferred. The inventive agent can be used in the form of an infusion, in an oral or rectal form of administration, or as an irrigation in cancer therapy.
    Type: Grant
    Filed: October 13, 2003
    Date of Patent: December 21, 2010
    Assignees: C.Y.L. Pharmazeutika GmbH
    Inventors: Karl Groke, Ilse Groke, legal representative, Veronika Groke, legal representative, Paul Groke, legal representative, Ralf Herwig, Peter Ferdinand
  • Publication number: 20060292218
    Abstract: Disclosed is an agent which has a destructive effect on malignant tumors and contains alpha-ketoglutaric acid, N-acetyl-seleno-L-methionine, N-acetyl-L-methionine, and a compound that is capable of forming azomethine and is selected among the group 5-hydroxymethylfurfural, dehydroascorbic acid, maltol, and vanillin as an active substance, 5-hydroxymethylfurfural being preferred. The inventive agent can be used in the form of an infusion, in an oral or rectal form of administration, or as an irrigation in cancer therapy.
    Type: Application
    Filed: October 13, 2003
    Publication date: December 28, 2006
    Inventors: Karl Groke, Ilse Groke, Veronika Groke, Paul Groke, Ralf Herwig, Peter Ferdinand